These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37620562)

  • 1. Animal models to study the neurological manifestations of the post-COVID-19 condition.
    Usai C; Mateu L; Brander C; Vergara-Alert J; Segalés J
    Lab Anim (NY); 2023 Sep; 52(9):202-210. PubMed ID: 37620562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
    Tiwari S; Goel G; Kumar A
    Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
    Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM
    Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of animal models for COVID-19.
    Qi F; Qin C
    Animal Model Exp Med; 2022 Oct; 5(5):401-409. PubMed ID: 36301011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central Nervous System and Psychiatric Complications in Long Coronavirus Disease 2019].
    Hagiya H; Otsuka F
    No Shinkei Geka; 2022 Sep; 50(5):1071-1077. PubMed ID: 36128823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal Models for the Study of Neurologic Manifestations Of COVID-19.
    Carpenter KC; Yang J; Xu JJ
    Comp Med; 2023 Feb; 73(1):91-103. PubMed ID: 36744556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Neurological Manifestations of SARS-CoV-2.
    Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
    Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection.
    Jacobs LMC; Wintjens MSJN; Nagy M; Willems L; Ten Cate H; Spronk HMH; van Kuijk SMJ; Ghossein-Doha C; Netea MG; Groh LA; van Petersen AS; Warlé MC
    Front Immunol; 2023; 14():1182182. PubMed ID: 37868959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
    PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis.
    Soung AL; Vanderheiden A; Nordvig AS; Sissoko CA; Canoll P; Mariani MB; Jiang X; Bricker T; Rosoklija GB; Arango V; Underwood M; Mann JJ; Dwork AJ; Goldman JE; Boon ACM; Boldrini M; Klein RS
    Brain; 2022 Dec; 145(12):4193-4201. PubMed ID: 36004663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.
    Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D
    Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.